Drug Research
Expansion of Biomedical Research On The Cards In Australia
Monash University- Australia has gone on to buy a prominent Parkville property that will go on to become a major addition to its campus, which is home to the world-leading Faculty of Pharmacy and Pharmaceutical Sciences, and thereby unprecedentedly...
Drug Research
Japan To Make Its Preparedness & Response To Pandemic Robust
The Coalition For Epidemic Preparedness Innovation in Norway and the Strategic Centre of Biomedical Advanced Vaccine Research and Development for Preparedness and Response have gone on to sign a Memorandum of Cooperation- MoC so as to strengthen the partnership...
Drug Research
China Remains An Attractive Market For Pharma Investment
A collection of notable recent developments in the Chinese pharmaceutical industry indicates that despite ongoing political tensions, multinational pharmaceutical companies still find China an appealing market for investment.
AstraZeneca defies geopolitics to bet on China – Financial Times (paywalled)
AstraZeneca's CEO...
Drug Research
Promising Future For The Global CRO Market With 8.4% CAGR
As per insights, the global clinical research organization (CRO) market is projected to achieve a value of $139.56 billion by 2033. The market is expected to CAGR (experience a compound annual growth rate) of 8.4 percent between 2023 and...
Drug Research
Medicare Drug Price Negotiations See New Guidance From CMS
The Biden administration has issued new guidelines for its program that enables Medicare to directly negotiate drug prices with manufacturers. The updated guidelines provide clarity on how the Centers for Medicare & Medicaid Services (CMS) will identify the drugs...
Drug Research
Pharma Industry Argues Unconstitutionality In Price-Settings
NICA, PhRMA, and GCCA lodged a complaint in the U.S. District Court for the Western District of Texas, asserting that the price setting provisions outlined in the Inflation Reduction Act infringe upon the Constitution. They argue that these provisions...
Drug Research
Pharma Trade Group Sues US Government On Medicare Drug Costs
On June 21, the pharma sector’s biggest lobbying group, along with two major organisations, went on to sue the Biden administration when it came to the new powers of Medicare to cut medicine prices for seniors as per the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















